Skip to main content

IQVIA s Value Stock - Dividend - Research Selection

IQVIA Holdings

ISIN: US46266C1053, WKN: A2JSPM

Market price date: 26.01.2022
Market price: 232,64 USD

IQVIA Holdings Fundamental data and company key figures of the share

Annual reports in USD
Key figures 26-03-2021
Cash flow
Net operating cash flow 1.959.000.000
Capital Expenditures -616.000.000
Free cash flow 1.343.000.064
Balance sheet
Total Equity
Liabilities & Shareholders equity 24.564.000.000
Income statement
Net income 279.000.000
Eps (diluted) 1,430
Diluted shares outstanding 195.000.000
Net sales/revenue 11.359.000.000

Fundamental ratios calculated on: 26-01-2022

Key figures 26-01-2022
Cash flow
P/C 23,51
P/FC 33,78
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization46.064.848.896,00 USD
CountryUnited States
IndicesS&P 500,MSCI World Index
SectorsLife Sciences Tools & Services
Raw Data SourceUS GAAP in Millionen USD
Stock Split

Description of the company

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Sheila A. Stamps Joins IQVIA Board of Directors

IQVIA today announced the appointment of Sheila A. Stamps to its board of directors, effective today. Ms. Stamps brings more than four decades of strategic, governance and operational management... | January 26, 2022

An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 50% Undervalued

Does the January share price for IQVIA Holdings Inc. (NYSE:IQV) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by estimating the company's future cash flows and discounting them to their present value. The Discounted Cash Flow (DCF) model i

Supplemental Annuity Collective Trust of NJ Buys Canadian Pacific Railway, Tesla Inc, IQVIA Holdings Inc, Sells , The Hain Celestial Group Inc, Synaptics Inc


Leslie Wims Morris Joins IQVIA Board of Directors

RESEARCH TRIANGLE PARK, N.C., January 24, 2022--IQVIA (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, announced the appointment of Leslie Wims Morris to its board of directors, effective today.

What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020

U.S. stock futures indicated more losses to start the new week following the Nasdaq's and the S&P 500's worst weeks since March 2020.

Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more

The stocks making the biggest moves in premarket trading include Kohl's, Snap, Peloton, and more.

IQVIA Holdings Takes Over #167 Spot From Roper Technologies

the online investor,IQV,ROP,

Earnings playbook: A complete guide to this week's reports, including the first of tech

Microsoft, Tesla and Apple will release quarterly results, alongside a handful of other tech firms. McDonald's and Boeing will also offer updates.

Markets are expected to remain on edge as the Fed meets in the week ahead

The Federal Reserve's meeting trumps everything else for markets in the week ahead, as investors await any new clues on its plans to raise interest rates.

Forte Capital Llc Buys AMN Healthcare Services Inc, IQVIA Holdings Inc, West Pharmaceutical ...

Investment company Forte Capital Llc (Current Portfolio) buys AMN Healthcare Services Inc, IQVIA Holdings Inc, West Pharmaceutical Services Inc, BlackRock Inc, Broadcom Inc, sells Analog Devices Inc, AT&T Inc, Amgen Inc, Dollar Tree Inc, VMware Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Forte Capital Llc .